Table 2.
Functions of tear lipocalin.
| Function | Interacting partner | References |
|---|---|---|
| Scavenger of toxic compounds | Prostaglandins, ceramides, phospholipid, thioredoxin | Redl et al., 1999; Lechner et al., 2001; Wojnar et al., 2002; Gasymov et al., 2005; Glasgow and Abduragimov, 2018b |
| Transport of vitamins, nutrient | Vitamins A and E | Hong, 1986; Redl et al., 1992; Gasymov et al., 2002a; Glasgow et al., 2002a |
| Endonuclease activity | DNA (human/microbial) | Yusifov et al., 2000, 2008 |
| Anti-microbial activity | Lipids, siderophores, lysozyme | Josephson and Wald, 1969; Kabara et al., 1972; Selsted and Martinez, 1982; Miller et al., 1988; Bibel et al., 1989; Fluckinger et al., 2004 |
| Acceptor protein for phospholipid transport protein | Phospholipid transport protein, phospholipid | Glasgow and Abduragimov, 2021 |
| Inhibitor of cysteine protease activity | Cysteine protease | Holzfeind et al., 1995; Van't Hof et al., 1997; Wojnar et al., 2001b |
| Viscosity (Confers non-newtonian sheer thinning behavior) | Polar lipids, lysozyme | Pandit et al., 1999; Tiffany and Nagyová, 2002; Gouveia and Tiffany, 2005 |
| Drug delivery native tear lipocalin | Rifampin | Gasymov et al., 2004a; Staudinger et al., 2014 |
| Drug delivery (Anti and duo-calins) | (e.g.,Vascular endothelial growth factor) | Eyer et al., 2012; Richter and Skerra, 2016 |